PL397662A1 - Terapia skojarzona niedrobnokomórkowego raka pluc - Google Patents

Terapia skojarzona niedrobnokomórkowego raka pluc

Info

Publication number
PL397662A1
PL397662A1 PL397662A PL39766211A PL397662A1 PL 397662 A1 PL397662 A1 PL 397662A1 PL 397662 A PL397662 A PL 397662A PL 39766211 A PL39766211 A PL 39766211A PL 397662 A1 PL397662 A1 PL 397662A1
Authority
PL
Poland
Prior art keywords
cell lung
small
combination therapy
lung carcinoma
combination
Prior art date
Application number
PL397662A
Other languages
English (en)
Other versions
PL226174B1 (pl
Inventor
Joanna Wietrzyk
Beata Filip-Psurska
Andrzej Kutner
Wiesław Szelejewski
Michał Chodyński
Original Assignee
Instytut Farmaceutyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Farmaceutyczny filed Critical Instytut Farmaceutyczny
Priority to PL397662A priority Critical patent/PL226174B1/pl
Priority to PCT/PL2012/000134 priority patent/WO2013100772A1/en
Publication of PL397662A1 publication Critical patent/PL397662A1/pl
Publication of PL226174B1 publication Critical patent/PL226174B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Wynalazek dotyczy terapii niedrobnokomórkowego raka pluc, w której skojarzenie z pochodnymi witamin D wzmaga dzialanie terapeutyczne inhibitora kinaz tyrozynowych imatinibu. Skladniki kombinacji - analogi witaminy D, korzystnie wybrane sa z grupy obejmujacej takalcytol i izomer 5,6-trans kalcypotriolu.
PL397662A 2011-12-30 2011-12-30 Polaczenie analogu witaminy D z imatinibem do stosowania w leczeniu skojarzonym niedrobnokomorkowego raka pluc PL226174B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL397662A PL226174B1 (pl) 2011-12-30 2011-12-30 Polaczenie analogu witaminy D z imatinibem do stosowania w leczeniu skojarzonym niedrobnokomorkowego raka pluc
PCT/PL2012/000134 WO2013100772A1 (en) 2011-12-30 2012-12-30 The use of vitamin d analogues in combination with imatinib in therapy of non-small cell lung cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL397662A PL226174B1 (pl) 2011-12-30 2011-12-30 Polaczenie analogu witaminy D z imatinibem do stosowania w leczeniu skojarzonym niedrobnokomorkowego raka pluc

Publications (2)

Publication Number Publication Date
PL397662A1 true PL397662A1 (pl) 2013-07-08
PL226174B1 PL226174B1 (pl) 2017-06-30

Family

ID=47666456

Family Applications (1)

Application Number Title Priority Date Filing Date
PL397662A PL226174B1 (pl) 2011-12-30 2011-12-30 Polaczenie analogu witaminy D z imatinibem do stosowania w leczeniu skojarzonym niedrobnokomorkowego raka pluc

Country Status (2)

Country Link
PL (1) PL226174B1 (pl)
WO (1) WO2013100772A1 (pl)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW225528B (pl) 1992-04-03 1994-06-21 Ciba Geigy Ag
CO4940418A1 (es) 1997-07-18 2000-07-24 Novartis Ag Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
WO2004098612A2 (en) * 2003-05-07 2004-11-18 Ab Science Calcitriol analogs of uses thereof
EP1631543A1 (en) * 2003-06-11 2006-03-08 Novacea, Inc. Treatment of lung cancer with active vitamin d compounds in combination with other treatments

Also Published As

Publication number Publication date
PL226174B1 (pl) 2017-06-30
WO2013100772A1 (en) 2013-07-04

Similar Documents

Publication Publication Date Title
CY1124928T1 (el) Αναστολεις πυραζολυλο κινοξαλινο κινασης
CY1121170T1 (el) Νεες ενωσεις ως ρυθμιστες πρωτεϊνικων κινασων
PH12018502125A1 (en) Bipyrazole derivatives as jak inhibitors
CY1120866T1 (el) Παρεμποδιστες dna-pk
BR112016029041A8 (pt) uso de um inibidor de glutaminase, composição farmacêutica e kit farmacêutico
CY1119615T1 (el) Διπλα εκλεκτικοι αναστολεις ρι3 δελτα και γαμμα κινασης
CL2014001547A1 (es) Compuestos derivados de benzotienilo-pirrolotriazina, como inhibidores de la proteina tirosina quinasa; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para el tratamiento y/o la prevencion de cancer y enfermedades tumorales.
MX2020012165A (es) Derivados de bencimidazol como inhibidores de tirosina cinasa erbb para el tratamiento del cancer.
MX2017004128A (es) Derivados de diarilurea como inhibidores de quinasa p38.
CY1122098T1 (el) Παραγωγα ισοχρωμενιου ως αναστολεις κινασων φωσφοϊνοσιτιδης-3
MX2013011908A (es) Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank.
EA033689B9 (ru) Ингибиторы g12c kras
BR112015029970A2 (pt) inibidores de cinase
UA111075C2 (uk) Триазолопіридинові сполуки як інгібітори кінази рім
EA201590391A1 (ru) Пиразолилмочевины в качестве ингибиторов киназы
BR112013001632A2 (pt) composto, composição farmacêutica, método de inibir uma atividade uma jak quinase in vitro, uso de um composto, ou da composição farmacêutica, e, método de fabricar um composto
EA201692313A1 (ru) Производные индолизина в качестве ингибиторов фосфоинозитид-3-киназ
MA32183B1 (fr) Pyrimidylcyclopentanes hydroxylés utilisés comme inhibiteurs de protéine kinase akt
GB201213484D0 (en) Pharmaceutical compositions comprising 15-OHEPA and methods of using the same
PH12014500536A1 (en) Compositions and methods for treating cancer using pi3k beta inhibitor and mapk pathway inhibitor, including mek and raf inhibitors
MX2015003535A (es) Dihidro-pirrolidino-pirimidinas como inhibidoras de cinasa.
EA201792445A1 (ru) Новые амидогетероарилароилгидразидэтины
PL397662A1 (pl) Terapia skojarzona niedrobnokomórkowego raka pluc
NZ739679A (en) Cholecalciferol sulfate salts and their use for the treatment of vitamin d deficiency
MY192305A (en) Bipyrazole derivatives as jak inhibitors